nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Estropipate—osteoporosis	0.125	0.198	CbGbCtD
Moclobemide—CYP2C9—Estropipate—osteoporosis	0.112	0.178	CbGbCtD
Moclobemide—CYP2C19—Cholecalciferol—osteoporosis	0.0695	0.11	CbGbCtD
Moclobemide—CYP1A2—Conjugated Estrogens—osteoporosis	0.0589	0.0935	CbGbCtD
Moclobemide—CYP2C9—Cholecalciferol—osteoporosis	0.0578	0.0917	CbGbCtD
Moclobemide—CYP2C19—Estradiol—osteoporosis	0.056	0.0889	CbGbCtD
Moclobemide—CYP2D6—Cholecalciferol—osteoporosis	0.0528	0.0839	CbGbCtD
Moclobemide—CYP1A2—Estradiol—osteoporosis	0.0517	0.0821	CbGbCtD
Moclobemide—CYP2C9—Estradiol—osteoporosis	0.0466	0.0739	CbGbCtD
Moclobemide—Constipation—Calcitriol—osteoporosis	0.000628	0.00172	CcSEcCtD
Moclobemide—Flatulence—Conjugated Estrogens—osteoporosis	0.000624	0.00171	CcSEcCtD
Moclobemide—Hypertension—Pamidronate—osteoporosis	0.000622	0.0017	CcSEcCtD
Moclobemide—Tension—Conjugated Estrogens—osteoporosis	0.000621	0.0017	CcSEcCtD
Moclobemide—Urticaria—Estropipate—osteoporosis	0.000621	0.0017	CcSEcCtD
Moclobemide—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00062	0.0017	CcSEcCtD
Moclobemide—Vision blurred—Zoledronate—osteoporosis	0.00062	0.00169	CcSEcCtD
Moclobemide—Gastrointestinal pain—Raloxifene—osteoporosis	0.000619	0.00169	CcSEcCtD
Moclobemide—Diarrhoea—Etidronic acid—osteoporosis	0.000619	0.00169	CcSEcCtD
Moclobemide—Abdominal pain—Estropipate—osteoporosis	0.000618	0.00169	CcSEcCtD
Moclobemide—Feeling abnormal—Ibandronate—osteoporosis	0.000618	0.00169	CcSEcCtD
Moclobemide—Tremor—Zoledronate—osteoporosis	0.000616	0.00168	CcSEcCtD
Moclobemide—Nervousness—Conjugated Estrogens—osteoporosis	0.000615	0.00168	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ibandronate—osteoporosis	0.000613	0.00168	CcSEcCtD
Moclobemide—Myalgia—Pamidronate—osteoporosis	0.000613	0.00168	CcSEcCtD
Moclobemide—Urticaria—Alendronate—osteoporosis	0.000612	0.00167	CcSEcCtD
Moclobemide—Anxiety—Pamidronate—osteoporosis	0.000611	0.00167	CcSEcCtD
Moclobemide—Ill-defined disorder—Zoledronate—osteoporosis	0.00061	0.00167	CcSEcCtD
Moclobemide—Abdominal pain—Alendronate—osteoporosis	0.000609	0.00166	CcSEcCtD
Moclobemide—Shock—Risedronate—osteoporosis	0.000608	0.00166	CcSEcCtD
Moclobemide—Discomfort—Pamidronate—osteoporosis	0.000606	0.00166	CcSEcCtD
Moclobemide—Agitation—Zoledronate—osteoporosis	0.000604	0.00165	CcSEcCtD
Moclobemide—Gastrointestinal pain—Calcitriol—osteoporosis	0.0006	0.00164	CcSEcCtD
Moclobemide—Abdominal pain—Raloxifene—osteoporosis	0.000599	0.00164	CcSEcCtD
Moclobemide—Vision blurred—Conjugated Estrogens—osteoporosis	0.000597	0.00163	CcSEcCtD
Moclobemide—Urticaria—Ibandronate—osteoporosis	0.000596	0.00163	CcSEcCtD
Moclobemide—Malaise—Zoledronate—osteoporosis	0.000593	0.00162	CcSEcCtD
Moclobemide—Abdominal pain—Ibandronate—osteoporosis	0.000593	0.00162	CcSEcCtD
Moclobemide—Confusional state—Pamidronate—osteoporosis	0.000592	0.00162	CcSEcCtD
Moclobemide—Syncope—Zoledronate—osteoporosis	0.00059	0.00161	CcSEcCtD
Moclobemide—Urticaria—Calcitriol—osteoporosis	0.000583	0.00159	CcSEcCtD
Moclobemide—Palpitations—Zoledronate—osteoporosis	0.000581	0.00159	CcSEcCtD
Moclobemide—Abdominal pain—Calcitriol—osteoporosis	0.00058	0.00159	CcSEcCtD
Moclobemide—Shock—Pamidronate—osteoporosis	0.000578	0.00158	CcSEcCtD
Moclobemide—Loss of consciousness—Zoledronate—osteoporosis	0.000578	0.00158	CcSEcCtD
Moclobemide—Vomiting—Etidronic acid—osteoporosis	0.000575	0.00157	CcSEcCtD
Moclobemide—Tachycardia—Pamidronate—osteoporosis	0.000573	0.00157	CcSEcCtD
Moclobemide—Rash—Etidronic acid—osteoporosis	0.00057	0.00156	CcSEcCtD
Moclobemide—Dermatitis—Etidronic acid—osteoporosis	0.000569	0.00156	CcSEcCtD
Moclobemide—Hyperhidrosis—Pamidronate—osteoporosis	0.000568	0.00155	CcSEcCtD
Moclobemide—Syncope—Conjugated Estrogens—osteoporosis	0.000568	0.00155	CcSEcCtD
Moclobemide—Hypertension—Zoledronate—osteoporosis	0.000568	0.00155	CcSEcCtD
Moclobemide—Headache—Etidronic acid—osteoporosis	0.000566	0.00155	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000563	0.00154	CcSEcCtD
Moclobemide—Asthenia—Estropipate—osteoporosis	0.000561	0.00153	CcSEcCtD
Moclobemide—Visual impairment—Estradiol—osteoporosis	0.000561	0.00153	CcSEcCtD
Moclobemide—Chest pain—Zoledronate—osteoporosis	0.00056	0.00153	CcSEcCtD
Moclobemide—Myalgia—Zoledronate—osteoporosis	0.00056	0.00153	CcSEcCtD
Moclobemide—Palpitations—Conjugated Estrogens—osteoporosis	0.00056	0.00153	CcSEcCtD
Moclobemide—Insomnia—Risedronate—osteoporosis	0.000559	0.00153	CcSEcCtD
Moclobemide—Anxiety—Zoledronate—osteoporosis	0.000558	0.00153	CcSEcCtD
Moclobemide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000557	0.00152	CcSEcCtD
Moclobemide—Paraesthesia—Risedronate—osteoporosis	0.000555	0.00152	CcSEcCtD
Moclobemide—Pruritus—Estropipate—osteoporosis	0.000553	0.00151	CcSEcCtD
Moclobemide—Discomfort—Zoledronate—osteoporosis	0.000553	0.00151	CcSEcCtD
Moclobemide—Asthenia—Alendronate—osteoporosis	0.000553	0.00151	CcSEcCtD
Moclobemide—Dyspnoea—Risedronate—osteoporosis	0.000551	0.00151	CcSEcCtD
Moclobemide—Hypotension—Pamidronate—osteoporosis	0.000549	0.0015	CcSEcCtD
Moclobemide—Dry mouth—Zoledronate—osteoporosis	0.000548	0.0015	CcSEcCtD
Moclobemide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000547	0.00149	CcSEcCtD
Moclobemide—Pruritus—Alendronate—osteoporosis	0.000545	0.00149	CcSEcCtD
Moclobemide—Dyspepsia—Risedronate—osteoporosis	0.000544	0.00149	CcSEcCtD
Moclobemide—Tinnitus—Estradiol—osteoporosis	0.000543	0.00148	CcSEcCtD
Moclobemide—Constipation—Ethinyl Estradiol—osteoporosis	0.000542	0.00148	CcSEcCtD
Moclobemide—Confusional state—Zoledronate—osteoporosis	0.000541	0.00148	CcSEcCtD
Moclobemide—Flushing—Estradiol—osteoporosis	0.00054	0.00148	CcSEcCtD
Moclobemide—Myalgia—Conjugated Estrogens—osteoporosis	0.000539	0.00147	CcSEcCtD
Moclobemide—Chest pain—Conjugated Estrogens—osteoporosis	0.000539	0.00147	CcSEcCtD
Moclobemide—Asthenia—Ibandronate—osteoporosis	0.000538	0.00147	CcSEcCtD
Moclobemide—Anxiety—Conjugated Estrogens—osteoporosis	0.000537	0.00147	CcSEcCtD
Moclobemide—Nausea—Etidronic acid—osteoporosis	0.000537	0.00147	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000535	0.00146	CcSEcCtD
Moclobemide—Diarrhoea—Estropipate—osteoporosis	0.000535	0.00146	CcSEcCtD
Moclobemide—Fatigue—Risedronate—osteoporosis	0.000533	0.00146	CcSEcCtD
Moclobemide—Insomnia—Pamidronate—osteoporosis	0.000531	0.00145	CcSEcCtD
Moclobemide—Pruritus—Ibandronate—osteoporosis	0.000531	0.00145	CcSEcCtD
Moclobemide—Constipation—Risedronate—osteoporosis	0.000529	0.00145	CcSEcCtD
Moclobemide—Shock—Zoledronate—osteoporosis	0.000528	0.00144	CcSEcCtD
Moclobemide—Paraesthesia—Pamidronate—osteoporosis	0.000528	0.00144	CcSEcCtD
Moclobemide—Diarrhoea—Alendronate—osteoporosis	0.000527	0.00144	CcSEcCtD
Moclobemide—Asthenia—Calcitriol—osteoporosis	0.000527	0.00144	CcSEcCtD
Moclobemide—Dyspnoea—Pamidronate—osteoporosis	0.000524	0.00143	CcSEcCtD
Moclobemide—Tachycardia—Zoledronate—osteoporosis	0.000524	0.00143	CcSEcCtD
Moclobemide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000522	0.00143	CcSEcCtD
Moclobemide—Somnolence—Pamidronate—osteoporosis	0.000522	0.00143	CcSEcCtD
Moclobemide—Pruritus—Calcitriol—osteoporosis	0.000519	0.00142	CcSEcCtD
Moclobemide—Hyperhidrosis—Zoledronate—osteoporosis	0.000519	0.00142	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000518	0.00142	CcSEcCtD
Moclobemide—Diarrhoea—Raloxifene—osteoporosis	0.000518	0.00142	CcSEcCtD
Moclobemide—Dyspepsia—Pamidronate—osteoporosis	0.000517	0.00141	CcSEcCtD
Moclobemide—Dizziness—Estropipate—osteoporosis	0.000517	0.00141	CcSEcCtD
Moclobemide—Diarrhoea—Ibandronate—osteoporosis	0.000513	0.0014	CcSEcCtD
Moclobemide—Decreased appetite—Pamidronate—osteoporosis	0.000511	0.0014	CcSEcCtD
Moclobemide—Dizziness—Alendronate—osteoporosis	0.000509	0.00139	CcSEcCtD
Moclobemide—Shock—Conjugated Estrogens—osteoporosis	0.000508	0.00139	CcSEcCtD
Moclobemide—Fatigue—Pamidronate—osteoporosis	0.000507	0.00138	CcSEcCtD
Moclobemide—Gastrointestinal pain—Risedronate—osteoporosis	0.000505	0.00138	CcSEcCtD
Moclobemide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000504	0.00138	CcSEcCtD
Moclobemide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000504	0.00138	CcSEcCtD
Moclobemide—Constipation—Pamidronate—osteoporosis	0.000502	0.00137	CcSEcCtD
Moclobemide—Diarrhoea—Calcitriol—osteoporosis	0.000502	0.00137	CcSEcCtD
Moclobemide—Hypotension—Zoledronate—osteoporosis	0.000501	0.00137	CcSEcCtD
Moclobemide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000501	0.00137	CcSEcCtD
Moclobemide—Dizziness—Raloxifene—osteoporosis	0.000501	0.00137	CcSEcCtD
Moclobemide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0005	0.00137	CcSEcCtD
Moclobemide—Flatulence—Estradiol—osteoporosis	0.000499	0.00137	CcSEcCtD
Moclobemide—Tension—Estradiol—osteoporosis	0.000497	0.00136	CcSEcCtD
Moclobemide—Vomiting—Estropipate—osteoporosis	0.000497	0.00136	CcSEcCtD
Moclobemide—Dysgeusia—Estradiol—osteoporosis	0.000496	0.00136	CcSEcCtD
Moclobemide—Dizziness—Ibandronate—osteoporosis	0.000496	0.00136	CcSEcCtD
Moclobemide—Rash—Estropipate—osteoporosis	0.000493	0.00135	CcSEcCtD
Moclobemide—Dermatitis—Estropipate—osteoporosis	0.000493	0.00135	CcSEcCtD
Moclobemide—Nervousness—Estradiol—osteoporosis	0.000492	0.00135	CcSEcCtD
Moclobemide—Urticaria—Risedronate—osteoporosis	0.000491	0.00134	CcSEcCtD
Moclobemide—Headache—Estropipate—osteoporosis	0.00049	0.00134	CcSEcCtD
Moclobemide—Vomiting—Alendronate—osteoporosis	0.00049	0.00134	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000489	0.00134	CcSEcCtD
Moclobemide—Abdominal pain—Risedronate—osteoporosis	0.000489	0.00134	CcSEcCtD
Moclobemide—Rash—Alendronate—osteoporosis	0.000486	0.00133	CcSEcCtD
Moclobemide—Insomnia—Zoledronate—osteoporosis	0.000485	0.00133	CcSEcCtD
Moclobemide—Dermatitis—Alendronate—osteoporosis	0.000485	0.00133	CcSEcCtD
Moclobemide—Feeling abnormal—Pamidronate—osteoporosis	0.000484	0.00132	CcSEcCtD
Moclobemide—Hypotension—Conjugated Estrogens—osteoporosis	0.000483	0.00132	CcSEcCtD
Moclobemide—Headache—Alendronate—osteoporosis	0.000483	0.00132	CcSEcCtD
Moclobemide—Paraesthesia—Zoledronate—osteoporosis	0.000482	0.00132	CcSEcCtD
Moclobemide—Vomiting—Raloxifene—osteoporosis	0.000482	0.00132	CcSEcCtD
Moclobemide—Gastrointestinal pain—Pamidronate—osteoporosis	0.00048	0.00131	CcSEcCtD
Moclobemide—Dyspnoea—Zoledronate—osteoporosis	0.000478	0.00131	CcSEcCtD
Moclobemide—Rash—Raloxifene—osteoporosis	0.000478	0.00131	CcSEcCtD
Moclobemide—Dermatitis—Raloxifene—osteoporosis	0.000477	0.0013	CcSEcCtD
Moclobemide—Somnolence—Zoledronate—osteoporosis	0.000477	0.0013	CcSEcCtD
Moclobemide—Vomiting—Ibandronate—osteoporosis	0.000477	0.0013	CcSEcCtD
Moclobemide—Tremor—Estradiol—osteoporosis	0.000475	0.0013	CcSEcCtD
Moclobemide—Headache—Raloxifene—osteoporosis	0.000475	0.0013	CcSEcCtD
Moclobemide—Rash—Ibandronate—osteoporosis	0.000473	0.00129	CcSEcCtD
Moclobemide—Dermatitis—Ibandronate—osteoporosis	0.000472	0.00129	CcSEcCtD
Moclobemide—Dyspepsia—Zoledronate—osteoporosis	0.000472	0.00129	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000471	0.00129	CcSEcCtD
Moclobemide—Ill-defined disorder—Estradiol—osteoporosis	0.00047	0.00129	CcSEcCtD
Moclobemide—Headache—Ibandronate—osteoporosis	0.00047	0.00128	CcSEcCtD
Moclobemide—Insomnia—Conjugated Estrogens—osteoporosis	0.000467	0.00128	CcSEcCtD
Moclobemide—Vomiting—Calcitriol—osteoporosis	0.000467	0.00128	CcSEcCtD
Moclobemide—Decreased appetite—Zoledronate—osteoporosis	0.000467	0.00128	CcSEcCtD
Moclobemide—Agitation—Estradiol—osteoporosis	0.000466	0.00127	CcSEcCtD
Moclobemide—Nausea—Estropipate—osteoporosis	0.000465	0.00127	CcSEcCtD
Moclobemide—Abdominal pain—Pamidronate—osteoporosis	0.000464	0.00127	CcSEcCtD
Moclobemide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000464	0.00127	CcSEcCtD
Moclobemide—Rash—Calcitriol—osteoporosis	0.000463	0.00127	CcSEcCtD
Moclobemide—Fatigue—Zoledronate—osteoporosis	0.000463	0.00127	CcSEcCtD
Moclobemide—Dermatitis—Calcitriol—osteoporosis	0.000462	0.00126	CcSEcCtD
Moclobemide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000461	0.00126	CcSEcCtD
Moclobemide—Headache—Calcitriol—osteoporosis	0.00046	0.00126	CcSEcCtD
Moclobemide—Somnolence—Conjugated Estrogens—osteoporosis	0.000459	0.00126	CcSEcCtD
Moclobemide—Constipation—Zoledronate—osteoporosis	0.000459	0.00125	CcSEcCtD
Moclobemide—Nausea—Alendronate—osteoporosis	0.000458	0.00125	CcSEcCtD
Moclobemide—Malaise—Estradiol—osteoporosis	0.000457	0.00125	CcSEcCtD
Moclobemide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000455	0.00124	CcSEcCtD
Moclobemide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000455	0.00124	CcSEcCtD
Moclobemide—Syncope—Estradiol—osteoporosis	0.000454	0.00124	CcSEcCtD
Moclobemide—Nausea—Raloxifene—osteoporosis	0.00045	0.00123	CcSEcCtD
Moclobemide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000449	0.00123	CcSEcCtD
Moclobemide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000448	0.00123	CcSEcCtD
Moclobemide—Palpitations—Estradiol—osteoporosis	0.000448	0.00122	CcSEcCtD
Moclobemide—Fatigue—Conjugated Estrogens—osteoporosis	0.000446	0.00122	CcSEcCtD
Moclobemide—Nausea—Ibandronate—osteoporosis	0.000445	0.00122	CcSEcCtD
Moclobemide—Loss of consciousness—Estradiol—osteoporosis	0.000445	0.00122	CcSEcCtD
Moclobemide—Asthenia—Risedronate—osteoporosis	0.000443	0.00121	CcSEcCtD
Moclobemide—Feeling abnormal—Zoledronate—osteoporosis	0.000442	0.00121	CcSEcCtD
Moclobemide—Constipation—Conjugated Estrogens—osteoporosis	0.000442	0.00121	CcSEcCtD
Moclobemide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000439	0.0012	CcSEcCtD
Moclobemide—Hypertension—Estradiol—osteoporosis	0.000438	0.0012	CcSEcCtD
Moclobemide—Pruritus—Risedronate—osteoporosis	0.000437	0.0012	CcSEcCtD
Moclobemide—Nausea—Calcitriol—osteoporosis	0.000436	0.00119	CcSEcCtD
Moclobemide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000434	0.00119	CcSEcCtD
Moclobemide—Myalgia—Estradiol—osteoporosis	0.000431	0.00118	CcSEcCtD
Moclobemide—Chest pain—Estradiol—osteoporosis	0.000431	0.00118	CcSEcCtD
Moclobemide—Anxiety—Estradiol—osteoporosis	0.00043	0.00118	CcSEcCtD
Moclobemide—Urticaria—Zoledronate—osteoporosis	0.000426	0.00117	CcSEcCtD
Moclobemide—Discomfort—Estradiol—osteoporosis	0.000426	0.00117	CcSEcCtD
Moclobemide—Abdominal pain—Zoledronate—osteoporosis	0.000424	0.00116	CcSEcCtD
Moclobemide—Diarrhoea—Risedronate—osteoporosis	0.000423	0.00116	CcSEcCtD
Moclobemide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000423	0.00116	CcSEcCtD
Moclobemide—Dry mouth—Estradiol—osteoporosis	0.000422	0.00115	CcSEcCtD
Moclobemide—Asthenia—Pamidronate—osteoporosis	0.000422	0.00115	CcSEcCtD
Moclobemide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000419	0.00115	CcSEcCtD
Moclobemide—Confusional state—Estradiol—osteoporosis	0.000417	0.00114	CcSEcCtD
Moclobemide—Pruritus—Pamidronate—osteoporosis	0.000416	0.00114	CcSEcCtD
Moclobemide—Urticaria—Conjugated Estrogens—osteoporosis	0.000411	0.00112	CcSEcCtD
Moclobemide—Dizziness—Risedronate—osteoporosis	0.000409	0.00112	CcSEcCtD
Moclobemide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000409	0.00112	CcSEcCtD
Moclobemide—Shock—Estradiol—osteoporosis	0.000407	0.00111	CcSEcCtD
Moclobemide—Tachycardia—Estradiol—osteoporosis	0.000404	0.0011	CcSEcCtD
Moclobemide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000403	0.0011	CcSEcCtD
Moclobemide—Diarrhoea—Pamidronate—osteoporosis	0.000402	0.0011	CcSEcCtD
Moclobemide—Hyperhidrosis—Estradiol—osteoporosis	0.0004	0.00109	CcSEcCtD
Moclobemide—Rash—Ethinyl Estradiol—osteoporosis	0.0004	0.00109	CcSEcCtD
Moclobemide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000399	0.00109	CcSEcCtD
Moclobemide—Headache—Ethinyl Estradiol—osteoporosis	0.000397	0.00109	CcSEcCtD
Moclobemide—Vomiting—Risedronate—osteoporosis	0.000393	0.00107	CcSEcCtD
Moclobemide—Rash—Risedronate—osteoporosis	0.00039	0.00107	CcSEcCtD
Moclobemide—Dermatitis—Risedronate—osteoporosis	0.000389	0.00106	CcSEcCtD
Moclobemide—Dizziness—Pamidronate—osteoporosis	0.000389	0.00106	CcSEcCtD
Moclobemide—Headache—Risedronate—osteoporosis	0.000387	0.00106	CcSEcCtD
Moclobemide—Asthenia—Zoledronate—osteoporosis	0.000385	0.00105	CcSEcCtD
Moclobemide—Pruritus—Zoledronate—osteoporosis	0.00038	0.00104	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000377	0.00103	CcSEcCtD
Moclobemide—Nausea—Ethinyl Estradiol—osteoporosis	0.000377	0.00103	CcSEcCtD
Moclobemide—Insomnia—Estradiol—osteoporosis	0.000374	0.00102	CcSEcCtD
Moclobemide—Vomiting—Pamidronate—osteoporosis	0.000374	0.00102	CcSEcCtD
Moclobemide—Paraesthesia—Estradiol—osteoporosis	0.000371	0.00102	CcSEcCtD
Moclobemide—Asthenia—Conjugated Estrogens—osteoporosis	0.000371	0.00101	CcSEcCtD
Moclobemide—Rash—Pamidronate—osteoporosis	0.00037	0.00101	CcSEcCtD
Moclobemide—Dermatitis—Pamidronate—osteoporosis	0.00037	0.00101	CcSEcCtD
Moclobemide—Dyspnoea—Estradiol—osteoporosis	0.000369	0.00101	CcSEcCtD
Moclobemide—Headache—Pamidronate—osteoporosis	0.000368	0.00101	CcSEcCtD
Moclobemide—Somnolence—Estradiol—osteoporosis	0.000368	0.00101	CcSEcCtD
Moclobemide—Diarrhoea—Zoledronate—osteoporosis	0.000367	0.001	CcSEcCtD
Moclobemide—Nausea—Risedronate—osteoporosis	0.000367	0.001	CcSEcCtD
Moclobemide—Pruritus—Conjugated Estrogens—osteoporosis	0.000366	0.001	CcSEcCtD
Moclobemide—Dyspepsia—Estradiol—osteoporosis	0.000364	0.000995	CcSEcCtD
Moclobemide—Decreased appetite—Estradiol—osteoporosis	0.00036	0.000983	CcSEcCtD
Moclobemide—Fatigue—Estradiol—osteoporosis	0.000357	0.000975	CcSEcCtD
Moclobemide—Dizziness—Zoledronate—osteoporosis	0.000355	0.00097	CcSEcCtD
Moclobemide—Constipation—Estradiol—osteoporosis	0.000354	0.000967	CcSEcCtD
Moclobemide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000354	0.000967	CcSEcCtD
Moclobemide—Nausea—Pamidronate—osteoporosis	0.000349	0.000954	CcSEcCtD
Moclobemide—Dizziness—Conjugated Estrogens—osteoporosis	0.000342	0.000934	CcSEcCtD
Moclobemide—Vomiting—Zoledronate—osteoporosis	0.000341	0.000933	CcSEcCtD
Moclobemide—Feeling abnormal—Estradiol—osteoporosis	0.000341	0.000932	CcSEcCtD
Moclobemide—Rash—Zoledronate—osteoporosis	0.000338	0.000925	CcSEcCtD
Moclobemide—Gastrointestinal pain—Estradiol—osteoporosis	0.000338	0.000925	CcSEcCtD
Moclobemide—Dermatitis—Zoledronate—osteoporosis	0.000338	0.000924	CcSEcCtD
Moclobemide—Headache—Zoledronate—osteoporosis	0.000336	0.000919	CcSEcCtD
Moclobemide—Vomiting—Conjugated Estrogens—osteoporosis	0.000329	0.000898	CcSEcCtD
Moclobemide—Urticaria—Estradiol—osteoporosis	0.000329	0.000898	CcSEcCtD
Moclobemide—Abdominal pain—Estradiol—osteoporosis	0.000327	0.000894	CcSEcCtD
Moclobemide—Rash—Conjugated Estrogens—osteoporosis	0.000326	0.000891	CcSEcCtD
Moclobemide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000326	0.00089	CcSEcCtD
Moclobemide—Headache—Conjugated Estrogens—osteoporosis	0.000324	0.000885	CcSEcCtD
Moclobemide—Nausea—Zoledronate—osteoporosis	0.000319	0.000872	CcSEcCtD
Moclobemide—Nausea—Conjugated Estrogens—osteoporosis	0.000307	0.000839	CcSEcCtD
Moclobemide—Asthenia—Estradiol—osteoporosis	0.000297	0.000811	CcSEcCtD
Moclobemide—Pruritus—Estradiol—osteoporosis	0.000293	0.0008	CcSEcCtD
Moclobemide—Diarrhoea—Estradiol—osteoporosis	0.000283	0.000774	CcSEcCtD
Moclobemide—Dizziness—Estradiol—osteoporosis	0.000273	0.000748	CcSEcCtD
Moclobemide—Vomiting—Estradiol—osteoporosis	0.000263	0.000719	CcSEcCtD
Moclobemide—Rash—Estradiol—osteoporosis	0.000261	0.000713	CcSEcCtD
Moclobemide—Dermatitis—Estradiol—osteoporosis	0.000261	0.000712	CcSEcCtD
Moclobemide—Headache—Estradiol—osteoporosis	0.000259	0.000708	CcSEcCtD
Moclobemide—Nausea—Estradiol—osteoporosis	0.000246	0.000672	CcSEcCtD
Moclobemide—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	5.06e-05	0.0118	CbGpPWpGaD
Moclobemide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.01e-05	0.0117	CbGpPWpGaD
Moclobemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	4.96e-05	0.0116	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—CYP27A1—osteoporosis	4.95e-05	0.0115	CbGpPWpGaD
Moclobemide—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	4.94e-05	0.0115	CbGpPWpGaD
Moclobemide—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	4.9e-05	0.0114	CbGpPWpGaD
Moclobemide—MAOA—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.9e-05	0.0114	CbGpPWpGaD
Moclobemide—MAOB—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.69e-05	0.0109	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—GAPDH—osteoporosis	4.47e-05	0.0104	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.41e-05	0.0103	CbGpPWpGaD
Moclobemide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	4.24e-05	0.00989	CbGpPWpGaD
Moclobemide—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	4.19e-05	0.00976	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—CYP19A1—osteoporosis	4.15e-05	0.00967	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.06e-05	0.00946	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.02e-05	0.00938	CbGpPWpGaD
Moclobemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.59e-05	0.00837	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	3.44e-05	0.00802	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—ESR2—osteoporosis	3.1e-05	0.00722	CbGpPWpGaD
Moclobemide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.07e-05	0.00715	CbGpPWpGaD
Moclobemide—MAOA—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.94e-05	0.00686	CbGpPWpGaD
Moclobemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.86e-05	0.00667	CbGpPWpGaD
Moclobemide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.82e-05	0.00658	CbGpPWpGaD
Moclobemide—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	2.76e-05	0.00643	CbGpPWpGaD
Moclobemide—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	2.69e-05	0.00628	CbGpPWpGaD
Moclobemide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.63e-05	0.00613	CbGpPWpGaD
Moclobemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.61e-05	0.00608	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—CYP19A1—osteoporosis	2.6e-05	0.00607	CbGpPWpGaD
Moclobemide—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.6e-05	0.00605	CbGpPWpGaD
Moclobemide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.57e-05	0.006	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—POMC—osteoporosis	2.49e-05	0.00581	CbGpPWpGaD
Moclobemide—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	2.46e-05	0.00573	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PKM—osteoporosis	2.35e-05	0.00548	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—FDPS—osteoporosis	2.35e-05	0.00548	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	2.34e-05	0.00547	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.32e-05	0.00541	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	2.31e-05	0.00539	CbGpPWpGaD
Moclobemide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.23e-05	0.0052	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PGLS—osteoporosis	2.23e-05	0.00519	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GPD2—osteoporosis	2.23e-05	0.00519	CbGpPWpGaD
Moclobemide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.2e-05	0.00513	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	2.16e-05	0.00503	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	2.14e-05	0.00498	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.13e-05	0.00497	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	2.13e-05	0.00496	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.11e-05	0.00493	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	2.11e-05	0.00492	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	2.1e-05	0.00489	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ATIC—osteoporosis	2.04e-05	0.00475	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PNP—osteoporosis	2.04e-05	0.00475	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—ADCY5—osteoporosis	1.88e-05	0.00439	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	1.84e-05	0.00429	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	1.83e-05	0.00426	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.81e-05	0.00421	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	1.8e-05	0.0042	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CA2—osteoporosis	1.73e-05	0.00404	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—OXCT1—osteoporosis	1.73e-05	0.00404	CbGpPWpGaD
Moclobemide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.72e-05	0.00401	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MGLL—osteoporosis	1.69e-05	0.00394	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.65e-05	0.00385	CbGpPWpGaD
Moclobemide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.58e-05	0.00369	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.57e-05	0.00365	CbGpPWpGaD
Moclobemide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.57e-05	0.00365	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—POMC—osteoporosis	1.56e-05	0.00365	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.49e-05	0.00346	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PKM—osteoporosis	1.47e-05	0.00344	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—FDPS—osteoporosis	1.47e-05	0.00344	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—ADCY5—osteoporosis	1.44e-05	0.00337	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—IDH2—osteoporosis	1.44e-05	0.00335	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.43e-05	0.00333	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PGLS—osteoporosis	1.4e-05	0.00326	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPD2—osteoporosis	1.4e-05	0.00326	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.39e-05	0.00325	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.36e-05	0.00316	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP27A1—osteoporosis	1.35e-05	0.00315	CbGpPWpGaD
Moclobemide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.34e-05	0.00312	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ACP5—osteoporosis	1.31e-05	0.00306	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.28e-05	0.00299	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ATIC—osteoporosis	1.28e-05	0.00298	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PNP—osteoporosis	1.28e-05	0.00298	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.27e-05	0.00296	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.25e-05	0.00293	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	1.23e-05	0.00287	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	1.23e-05	0.00287	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.22e-05	0.00285	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TPI1—osteoporosis	1.22e-05	0.00285	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	1.21e-05	0.00283	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.16e-05	0.0027	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.16e-05	0.00269	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—P4HB—osteoporosis	1.15e-05	0.00268	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	1.13e-05	0.00264	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GAPDH—osteoporosis	1.13e-05	0.00263	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.13e-05	0.00263	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.12e-05	0.00262	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	1.12e-05	0.0026	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.11e-05	0.00258	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—RAP1A—osteoporosis	1.1e-05	0.00256	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CA2—osteoporosis	1.09e-05	0.00254	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—OXCT1—osteoporosis	1.09e-05	0.00254	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.09e-05	0.00253	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MGLL—osteoporosis	1.06e-05	0.00247	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.05e-05	0.00246	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.03e-05	0.00239	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	9.6e-06	0.00224	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	9.58e-06	0.00223	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	9.55e-06	0.00223	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	9.46e-06	0.00221	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TNF—osteoporosis	9.1e-06	0.00212	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—IDH2—osteoporosis	9.01e-06	0.0021	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9e-06	0.0021	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9e-06	0.0021	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	8.92e-06	0.00208	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	8.92e-06	0.00208	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ENO1—osteoporosis	8.87e-06	0.00207	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.78e-06	0.00205	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSMA5—osteoporosis	8.74e-06	0.00204	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSMA2—osteoporosis	8.74e-06	0.00204	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP27A1—osteoporosis	8.47e-06	0.00197	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ACP5—osteoporosis	8.24e-06	0.00192	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.21e-06	0.00191	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TPI1—osteoporosis	7.66e-06	0.00179	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.66e-06	0.00178	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—POMC—osteoporosis	7.4e-06	0.00173	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	7.35e-06	0.00171	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—P4HB—osteoporosis	7.2e-06	0.00168	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP19A1—osteoporosis	7.09e-06	0.00165	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GAPDH—osteoporosis	7.07e-06	0.00165	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.02e-06	0.00164	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PKM—osteoporosis	6.98e-06	0.00163	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—FDPS—osteoporosis	6.98e-06	0.00163	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.98e-06	0.00163	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—RAP1A—osteoporosis	6.89e-06	0.00161	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—POMC—osteoporosis	6.81e-06	0.00159	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—POMC—osteoporosis	6.75e-06	0.00157	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PGLS—osteoporosis	6.62e-06	0.00154	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPD2—osteoporosis	6.62e-06	0.00154	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PKM—osteoporosis	6.42e-06	0.0015	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—FDPS—osteoporosis	6.42e-06	0.0015	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—FDPS—osteoporosis	6.37e-06	0.00148	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PKM—osteoporosis	6.37e-06	0.00148	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPD2—osteoporosis	6.09e-06	0.00142	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PGLS—osteoporosis	6.09e-06	0.00142	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ATIC—osteoporosis	6.05e-06	0.00141	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PNP—osteoporosis	6.05e-06	0.00141	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PGLS—osteoporosis	6.03e-06	0.00141	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPD2—osteoporosis	6.03e-06	0.00141	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.97e-06	0.00139	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ADCY5—osteoporosis	5.79e-06	0.00135	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GPX1—osteoporosis	5.77e-06	0.00135	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—POMC—osteoporosis	5.77e-06	0.00134	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PNP—osteoporosis	5.57e-06	0.0013	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ATIC—osteoporosis	5.57e-06	0.0013	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ENO1—osteoporosis	5.57e-06	0.0013	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ATIC—osteoporosis	5.52e-06	0.00129	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PNP—osteoporosis	5.52e-06	0.00129	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSMA5—osteoporosis	5.48e-06	0.00128	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSMA2—osteoporosis	5.48e-06	0.00128	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PKM—osteoporosis	5.44e-06	0.00127	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—FDPS—osteoporosis	5.44e-06	0.00127	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MTHFR—osteoporosis	5.33e-06	0.00124	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PGLS—osteoporosis	5.16e-06	0.0012	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPD2—osteoporosis	5.16e-06	0.0012	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA2—osteoporosis	5.15e-06	0.0012	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—OXCT1—osteoporosis	5.15e-06	0.0012	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MGLL—osteoporosis	5.02e-06	0.00117	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—OXCT1—osteoporosis	4.73e-06	0.0011	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA2—osteoporosis	4.73e-06	0.0011	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.73e-06	0.0011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PNP—osteoporosis	4.72e-06	0.0011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ATIC—osteoporosis	4.72e-06	0.0011	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—OXCT1—osteoporosis	4.69e-06	0.00109	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA2—osteoporosis	4.69e-06	0.00109	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MGLL—osteoporosis	4.61e-06	0.00108	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MGLL—osteoporosis	4.57e-06	0.00107	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP19A1—osteoporosis	4.45e-06	0.00104	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.31e-06	0.00101	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—IDH2—osteoporosis	4.26e-06	0.000994	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—POMC—osteoporosis	4.26e-06	0.000994	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—OXCT1—osteoporosis	4.01e-06	0.000935	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA2—osteoporosis	4.01e-06	0.000935	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP27A1—osteoporosis	4.01e-06	0.000935	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—IDH2—osteoporosis	3.92e-06	0.000914	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MGLL—osteoporosis	3.91e-06	0.000911	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACP5—osteoporosis	3.9e-06	0.000909	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—IDH2—osteoporosis	3.89e-06	0.000907	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.85e-06	0.000898	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.69e-06	0.00086	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.69e-06	0.000859	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP27A1—osteoporosis	3.66e-06	0.000852	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ADCY5—osteoporosis	3.64e-06	0.000848	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TPI1—osteoporosis	3.63e-06	0.000845	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPX1—osteoporosis	3.62e-06	0.000845	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACP5—osteoporosis	3.59e-06	0.000836	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACP5—osteoporosis	3.56e-06	0.000829	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.51e-06	0.000819	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—P4HB—osteoporosis	3.41e-06	0.000795	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GAPDH—osteoporosis	3.35e-06	0.00078	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—osteoporosis	3.34e-06	0.00078	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TPI1—osteoporosis	3.34e-06	0.000778	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—IDH2—osteoporosis	3.32e-06	0.000775	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TPI1—osteoporosis	3.31e-06	0.000771	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—RAP1A—osteoporosis	3.26e-06	0.00076	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—P4HB—osteoporosis	3.14e-06	0.000731	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.12e-06	0.000728	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—P4HB—osteoporosis	3.11e-06	0.000725	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GAPDH—osteoporosis	3.08e-06	0.000718	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GAPDH—osteoporosis	3.05e-06	0.000711	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACP5—osteoporosis	3.04e-06	0.000709	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3e-06	0.0007	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—RAP1A—osteoporosis	3e-06	0.000699	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—RAP1A—osteoporosis	2.97e-06	0.000693	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.84e-06	0.000663	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TPI1—osteoporosis	2.83e-06	0.000659	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—POMC—osteoporosis	2.67e-06	0.000623	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—P4HB—osteoporosis	2.66e-06	0.000619	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ENO1—osteoporosis	2.63e-06	0.000614	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GAPDH—osteoporosis	2.61e-06	0.000608	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSMA2—osteoporosis	2.6e-06	0.000605	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSMA5—osteoporosis	2.6e-06	0.000605	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.59e-06	0.000604	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—RAP1A—osteoporosis	2.54e-06	0.000592	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ENO1—osteoporosis	2.42e-06	0.000565	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ENO1—osteoporosis	2.4e-06	0.00056	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSMA2—osteoporosis	2.39e-06	0.000557	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSMA5—osteoporosis	2.39e-06	0.000557	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSMA2—osteoporosis	2.37e-06	0.000552	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSMA5—osteoporosis	2.37e-06	0.000552	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.21e-06	0.000516	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP19A1—osteoporosis	2.11e-06	0.000491	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ENO1—osteoporosis	2.05e-06	0.000479	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSMA2—osteoporosis	2.02e-06	0.000472	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSMA5—osteoporosis	2.02e-06	0.000472	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.94e-06	0.000452	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.92e-06	0.000448	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADCY5—osteoporosis	1.72e-06	0.000401	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPX1—osteoporosis	1.72e-06	0.0004	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.64e-06	0.000383	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADCY5—osteoporosis	1.58e-06	0.000369	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—osteoporosis	1.58e-06	0.000369	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPX1—osteoporosis	1.58e-06	0.000368	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADCY5—osteoporosis	1.57e-06	0.000366	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPX1—osteoporosis	1.56e-06	0.000365	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—osteoporosis	1.46e-06	0.000339	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—osteoporosis	1.44e-06	0.000336	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADCY5—osteoporosis	1.34e-06	0.000313	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX1—osteoporosis	1.34e-06	0.000312	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—POMC—osteoporosis	1.27e-06	0.000295	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—osteoporosis	1.23e-06	0.000288	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—POMC—osteoporosis	1.16e-06	0.000271	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—POMC—osteoporosis	1.15e-06	0.000269	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—POMC—osteoporosis	9.86e-07	0.00023	CbGpPWpGaD
